psoriatic arthritis (PsA)
Adaptation of Chinese and English versions of the Psoriatic Arthritis Quality of Life (PsAQoL) scale for use in Singapore
... the Psoriatic Arthritis Quality of Life (PsAQoL) scale that were equivalent to and met the same psychometric and acceptability standards as the original UK ...validity. Psoriatic arthritis ...
7
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population based cohort study
... rheumatoid arthritis (RA), cardiovascu- lar risk in SpA is less ...concomitant psoriatic arthritis (PsA) had particularly high risk of non-fatal CVD, which is in line with studies focusing on ...
12
Successful use of Ustekinumab in a Patient with Psoriasis, Psoriatic Arthritis and Systemic Lupus Erythematosus: A Case report and Review of literature
... Our patient is a 48-year-old man with history of psoriasis (Diagnosed in 2001), autoimmune hemolytic anemia (AIHA) treated with rituximab (diagnosed in 2006 and rituximab given in 2006), who presented to the rheumatology ...
5
Identification of low frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization
... for psoriatic arthritis and psoriasis vulgaris have been quite successful and revealed more than 25 new susceptibility loci [1-7] characterizing psoriatic arthritis (PsA), mainly as an ...
5
Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry
... for PsA have been vali- dated in various clinical settings; these tools include the Early Arthritis for Psoriatic Patients (EARP), 20 German PsO Arthritis Diagnostic questionnaire, 21 PsO ...
7
Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
... of PsA, results in patients enrolled in clin- ical trials are not necessarily generalisable to real-world clinical settings, where patients may present with a wider spectrum of disease, have multiple comorbidities ...
10
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
... of psoriatic arthritis (PsA) patients maintaining clinical remission after adalimumab (ADA) dose reduction compared with patients with rheumatoid ...of PsA patients who achieve remission, the ...
6
Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial
... psoriasis; PsA, psoriatic arthritis; PtGA, Patient Global Assessment of disease activity; SJC, swollen joint count of 76 joints; TJC, tender joint count of 78 ...
9
TCD4pos lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents
... lymphocytosis is often hard to establish. Thus, the search for markers helping in such discrimination is highly warranted. This is mainly felt when lymphocyte abnor- malities arise during the course of an immune-mediated ...
6
Change in CD3 positive T cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy a single centre, open label study
... Psoriatic arthritis is a chronic and debilitating inflamma- tory ...early arthritis clinics, and has considerable morbidity ...(OMERACT) PsA working group has identified a hierar- chy of ...
10
Effect of disease modifying anti rheumatic drugs on bone structure and strength in psoriatic arthritis patients
... for Psoriatic Arthritis (CAS- PAR) ...to psoriatic disease, duration of PsA, duration of psoriasis, minimal disease activity (MDA) state, disease activity in psoriatic arthritis ...
8
Utility of the Siriraj Psoriatic Arthritis Screening Tool, the Thai Psoriasis Epidemiology Screening Tool, and the Early Arthritis for Psoriatic Patients Questionnaire to Screen for Psoriatic Arthritis in an Outpatient Dermatology Clinic Setting, and Identification of Factors Significantly Associated with Psoriatic Arthritis
... An evaluation of patient medical records and physical examinations were then performed. Current non-steroidal anti-inflammatory drugs (NSAIDs) use was defined as current use or drug discontinuation for less than 2 weeks ...
9
Heterogeneous expression pattern of interleukin 17A (IL 17A), IL 17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti IL 17 therapy?
... addressin; PsA: Psoriatic arthritis; RA: Rheumatoid arthritis; RF: Rheumatoid factor; RORc: Retinoic acid receptor – related orphan receptor C; ROR γ : Retinoic acid receptor – related orphan ...
10
Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM PsA)
... The primary endpoint is the ACR20 response at week 24 and the key secondary endpoint is the Minimal Disease Activity (MDA) response at week 24. Other secondary endpoints include measures to characterise extra-ar- ticular ...
5
Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible
... with Psa were registered in iceBiO, of whom 231 had data available for their first start of tnFi and could be evaluated according to the inclusion criteria of the respective ...in Psoriatic arthritis ...
7
Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry
... Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory arthritis often characterized by inflam- mation of the peripheral joints, nail changes, enthesitis, and dactylitis, and is ...
10
Predictors of functional deterioration in Chinese patients with Psoriatic arthritis: a longitudinal study
... with PsA followed up in a single center were recruited to assessment using a standardized protocol from January 2006 to May ...of Psoriatic Arthritis (CASPAR) criteria for PsA ...These ...
6
Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype
... of psoriatic arthritis (PsA) and their relationship to phenotypic heterogeneity in the disease, and addresses three questions: what do the recent studies on human leukocyte antigen (HLA) tell us ...
11
Patient centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)
... Statistical evaluation of the prototype questionnaire Statistical evaluation was carried out using SPSS for Windows version 11.0. For internal consistency, assess- ment Cronbach’s alpha was calculated [26]. An alpha ...
8
Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis
... (rheumatoid arthritis, n = 2; psoriatic arthritis, n = 1) were assessed after 24-hour incubation with IL-3-supplemented media alone or contain- ing the TLR9 agonist CpG ODN 2216 ...
13